Literature DB >> 22382894

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.

S P Whitman, M A Caligiuri, K Maharry, M D Radmacher, J Kohlschmidt, H Becker, K Mrózek, Y-Z Wu, S Schwind, K H Metzeler, J H Mendler, J Wen, M R Baer, B L Powell, T H Carter, J E Kolitz, M Wetzler, A J Carroll, R A Larson, G Marcucci, C D Bloomfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22382894      PMCID： PMC3565839          DOI： 10.1038/leu.2012.34

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Authors:  Krzysztof Mrózek; Guido Marcucci; Peter Paschka; Susan P Whitman; Clara D Bloomfield
Journal:  Blood       Date:  2006-09-07       Impact factor: 22.113

2.  Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.

Authors:  M A Caligiuri; M P Strout; D Lawrence; D C Arthur; M R Baer; F Yu; S Knuutila; K Mrózek; A R Oberkircher; G Marcucci; A de la Chapelle; E Elonen; A W Block; P N Rao; G P Herzig; B L Powell; T Ruutu; C A Schiffer; C D Bloomfield
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

3.  Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Authors:  Lars Bullinger; Konstanze Döhner; Eric Bair; Stefan Fröhling; Richard F Schlenk; Robert Tibshirani; Hartmut Döhner; Jonathan R Pollack
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

4.  DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.

Authors:  Susan P Whitman; Björn Hackanson; Sandya Liyanarachchi; Shujun Liu; Laura J Rush; Kati Maharry; Dean Margeson; Ramana Davuluri; Jing Wen; Tatiana Witte; Li Yu; Chunhui Liu; Clara D Bloomfield; Guido Marcucci; Christoph Plass; Michael A Caligiuri
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

5.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

Authors:  Relja Popovic; Laurie E Riesbeck; Chinavenmeni S Velu; Aditya Chaubey; Jiwang Zhang; Nicholas J Achille; Frank E Erfurth; Katherine Eaton; Jun Lu; H Leighton Grimes; Jianjun Chen; Janet D Rowley; Nancy J Zeleznik-Le
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

6.  Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

Authors:  Richard F Schlenk; Konstanze Döhner; Michael Kneba; Katharina Götze; Frank Hartmann; Francesco Del Valle; Heinz Kirchen; Elisabeth Koller; Jörg T Fischer; Lars Bullinger; Marianne Habdank; Daniela Späth; Silja Groner; Bernhard Krebs; Sabine Kayser; Andrea Corbacioglu; Andreas Anhalt; Axel Benner; Stefan Fröhling; Hartmut Döhner
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

Review 7.  Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

Authors:  Hartmut Döhner; Elihu H Estey; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Alan K Burnett; Hervé Dombret; Pierre Fenaux; David Grimwade; Richard A Larson; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel A Sanz; Jorge Sierra; Martin S Tallman; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

8.  c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Authors:  Shenghao Jin; Huiwu Zhao; Yan Yi; Yuji Nakata; Anna Kalota; Alan M Gewirtz
Journal:  J Clin Invest       Date:  2010-01-19       Impact factor: 14.808

9.  Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor.

Authors:  Paloma García; Jon Frampton
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

10.  Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.

Authors:  Susan P Whitman; Amy S Ruppert; Guido Marcucci; Krzysztof Mrózek; Peter Paschka; Christian Langer; Claudia D Baldus; Jing Wen; Tamara Vukosavljevic; Bayard L Powell; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Michael A Caligiuri; Clara D Bloomfield
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113
View more
  7 in total

1.  MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.

Authors:  Michael W M Kühn; Michael J Hadler; Scott R Daigle; Richard P Koche; Andrei V Krivtsov; Edward J Olhava; Michael A Caligiuri; Gang Huang; James E Bradner; Roy M Pollock; Scott A Armstrong
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

2.  Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.

Authors:  Yue Zhang; Xiaomei Yan; Goro Sashida; Xinghui Zhao; Yalan Rao; Susumu Goyama; Susan P Whitman; Nicholas Zorko; Kelsie Bernot; Rajeana M Conway; David Witte; Qian-Fei Wang; Daniel G Tenen; Zhijian Xiao; Guido Marcucci; James C Mulloy; H Leighton Grimes; Michael A Caligiuri; Gang Huang
Journal:  Blood       Date:  2012-06-26       Impact factor: 22.113

3.  Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.

Authors:  Sylvain Mareschal; Anna Palau; Johan Lindberg; Philippe Ruminy; Christer Nilsson; Sofia Bengtzén; Marie Engvall; Anna Eriksson; Anne Neddermeyer; Vinciane Marchand; Monika Jansson; My Björklund; Fabrice Jardin; Mattias Rantalainen; Andreas Lennartsson; Lucia Cavelier; Henrik Grönberg; Sören Lehmann
Journal:  Blood Adv       Date:  2021-02-23

4.  Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells.

Authors:  Yin Wang; Yan Liu; Fei Tang; Kelsie M Bernot; Reuven Schore; Guido Marcucci; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2014-07-03       Impact factor: 22.113

5.  A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.

Authors:  K H Metzeler; K Maharry; J Kohlschmidt; S Volinia; K Mrózek; H Becker; D Nicolet; S P Whitman; J H Mendler; S Schwind; A-K Eisfeld; Y-Z Wu; B L Powell; T H Carter; M Wetzler; J E Kolitz; M R Baer; A J Carroll; R M Stone; M A Caligiuri; G Marcucci; C D Bloomfield
Journal:  Leukemia       Date:  2013-06-14       Impact factor: 11.528

6.  Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

Authors:  H A Hou; C C Lin; W C Chou; C Y Liu; C Y Chen; J L Tang; Y J Lai; M H Tseng; C F Huang; Y C Chiang; F Y Lee; Y Y Kuo; M C Lee; M C Liu; C W Liu; L I Lin; M Yao; S Y Huang; B S Ko; S C Hsu; S J Wu; W Tsay; Y C Chen; H F Tien
Journal:  Leukemia       Date:  2013-08-09       Impact factor: 11.528

7.  High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.

Authors:  Hsiao-Wen Kao; D Cherng Liang; Ming-Chung Kuo; Jin-Hou Wu; Po Dunn; Po-Nan Wang; Tung-Liang Lin; Yu-Shu Shih; Sung-Tzu Liang; Tung-Huei Lin; Chen-Yu Lai; Chun-Hui Lin; Lee-Yung Shih
Journal:  Oncotarget       Date:  2015-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.